Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report)’s share price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.28 and traded as low as $0.21. Northwest Biotherapeutics shares last traded at $0.23, with a volume of 3,564,085 shares.
Northwest Biotherapeutics Trading Down 3.2 %
The stock has a 50-day simple moving average of $0.26 and a 200 day simple moving average of $0.28. The stock has a market capitalization of $314.24 million, a price-to-earnings ratio of -2.84 and a beta of -0.52.
Northwest Biotherapeutics Company Profile
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
Featured Articles
- Five stocks we like better than Northwest Biotherapeutics
- Expert Stock Trading Psychology Tips
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- Learn Technical Analysis Skills to Master the Stock Market
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
